STOKE THERAPEUTICS INC COM is a security (CUSIP 86150R107) tracked across SEC portfolio filings. 191 institutional managers reported $2.3B on Form 13F as of 2026-06-30; 25 registered fund positions totaling $145.1M via N-PORT as of 2026-05-31.
Showing 15 of 191 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| RTW INVESTMENTS, LP | NEW YORK, NY | $183.1M | 5,623,525 |
| BlackRock, Inc. | New York, NY | $175.4M | 5,385,714 |
| FMR LLC | BOSTON, MA | $175.3M | 5,383,666 |
| Lynx1 Capital Management LP | SAN JUAN, PR | $155.1M | 4,763,673 |
| Redmile Group, LLC | San Francisco, CA | $135.6M | 4,164,120 |
| MORGAN STANLEY | NEW YORK, NY | $111.5M | 3,423,280 |
| BAKER BROS. ADVISORS LP | NEW YORK, NY | $108.6M | 3,336,697 |
| TORONTO DOMINION BANK | Toronto, Ontario, A6 | $103.3M | 3,173,258 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $100.8M | 3,095,700 |
| VANGUARD GROUP INC | Valley Forge, PA | $100.0M | 3,149,239 |
| BVF INC/IL | San Francisco, CA | $82.9M | 2,547,557 |
| STATE STREET CORP | BOSTON, MA | $74.1M | 2,276,512 |
| Siren, L.L.C. | New York, NY | $65.0M | 1,995,347 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | New York, NY | $59.4M | 1,823,500 |
| Skorpios Trust | LIMASSOL, G4 | $53.0M | 2,256,181 |
Showing 15 of 25 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD HEALTH CARE FUND | VANGUARD SPECIALIZED FUNDS | $54.1M | 14.67% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $18.7M | 2.29% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $15.7M | 12.32% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $14.7M | 13.51% |
| Fidelity Advisor Health Care Fund | Fidelity Advisor Series VII | $10.8M | 37.40% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $7.8M | 4.44% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $4.8M | 6.38% |
| BlackRock Health Sciences Term Trust | BlackRock Health Sciences Term Trust | $4.3M | 42.67% |
| T. Rowe Price Small-Cap Value Fund, Inc. | T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | $2.9M | 3.19% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $2.6M | 5.37% |
| VANGUARD U.S. MOMENTUM FACTOR ETF | VANGUARD WELLINGTON FUND | $2.3M | 12.63% |
| BlackRock Health Sciences Trust | BlackRock Health Sciences Trust | $1.3M | 25.12% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $1.0M | 0.17% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $912K | 13.76% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $868K | 0.29% |